Pseudorabies virus tegument protein UL13 recruits RNF5 to inhibit STING-mediated antiviral immunity

Zhengjie Kong1,2, Hongyan Yin1,2, Fan Wang1,2

  • 1Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Shandong Agricultural University, Taian, Shandong, China.

Plos Pathogens
|May 18, 2022
PubMed

Insights

Pseudorabies virus protein UL13 evades immunity by degrading STING, a key antiviral signaling molecule. This discovery reveals a new viral immune evasion strategy targeting the cGAS-STING pathway.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Pseudorabies virus (PRV) employs immune evasion strategies to counteract host defenses.
  • The cGAS-STING signaling pathway is crucial for detecting viral infections and initiating antiviral responses.
  • The precise mechanisms by which PRV proteins interfere with the cGAS-STING axis remain largely unknown.

Purpose of the Study:

  • To investigate whether PRV-encoded proteins modulate the cGAS-STING pathway for immune evasion.
  • To elucidate the specific role of PRV tegument protein UL13 in regulating STING-mediated antiviral signaling.

Main Methods:

  • Co-immunoprecipitation assays to identify protein interactions.
  • Ubiquitination assays to determine ubiquitination patterns.
  • Western blotting to assess protein stability and degradation.
  • Viral infection models in cell culture and mice to evaluate pathogenicity and immune responses.

Main Results:

  • PRV tegument protein UL13 directly interacts with STING.
  • UL13 recruits the E3 ligase RNF5 to promote STING ubiquitination and degradation.
  • UL13 deficiency in PRV leads to enhanced type I interferon production and reduced pathogenicity in mice.
  • RNF5 deficiency enhances antiviral responses against PRV infection.

Conclusions:

  • PRV UL13 inhibits STING-mediated antiviral signaling by promoting STING degradation.
  • This represents a novel mechanism of viral immune evasion targeting the cGAS-STING pathway.
  • UL13 antagonism of STING contributes to PRV's ability to evade host antiviral immunity and establish persistent infections.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
169
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K